Evidence map›Paper›PMID 41821401›Full record

ArticleMedical decision making : an international journal of the Society for Medical Decision Making2026

A Comparison of Methods for Modeling Multistate Cancer Progression Using Screening Data with Censoring after Intervention.

Eddymurphy U Akwiwu, Veerle M H Coupé, Johannes Berkhof, Thomas Klausch

Abstract readComparative Study
In one paragraph

Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eddymurphy U AkwiwuAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.ORCID 0000-0001-9730-7073
Veerle M H CoupéAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
Johannes BerkhofAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.
Thomas KlauschAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science, Amsterdam Public Health, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundOptimizing cancer screening and surveillance frequency requires accurate information on parameters such as sojourn time and cancer risk from premalignant lesions. These parameters can be estimated using multistate cancer models applied to screening or surveillance data. However, the performance of these models has not been thoroughly investigated in settings in which cancer precursors are treated upon detection, preventing progression to cancer. Our main goal is understanding the performance of available multistate methods in this challenging censoring setting.MethodsWe assumed progression hazards between consecutive health states in a 3-state model (healthy [HE], cancer precursor, and cancer) to be either time independent or dependent on time since state entry and compared 6 methods implemented in R software packages with varying assumptions: time-independent hazards (msm), hazards dependent on time since state entry (msm with a phase-type model, cthmm, smms, BayesTSM), and hazards dependent on time since the start of the process (hmm). Risk estimates from each method were compared in simulations and illustrated using colorectal cancer surveillance data from 734 individuals, classified into 3 health states: HE, non-advanced adenoma (nAA), and advanced neoplasia (AN).ResultsAll methods performed well with time-independent hazards in the simulation study. With hazards dependent on time since state entry, only smms and BayesTSM provided unbiased risk estimates. In the application, only msm,hmm, and BayesTSM yielded converged solutions. The nAA risk estimates were similar between hmm and BayesTSM but differed for msm, while AN risk estimates varied across methods.ConclusionsMethods for multistate cancer models, specifically with unobservable precursor-to-cancer transition, are strongly affected by the time dependency of the hazard. With time-dependent hazards since state entry, BayesTSM provided robust estimates, in both the simulation and application.HighlightsThis study presents the first comprehensive comparison of available multistate modeling options for screening and surveillance data, focusing on the specific setting of a 3-state progressive model (healthy, cancer precursor, cancer) in which cancer precursors are treated upon detection so that the transition to cancer is prevented (censoring after intervention). Sample R code and simulated data demonstrating the compared methods, along with documentation (including installation instructions, manual, and/or worked examples) for the corresponding R software packages, are available at https://github.com/EddymurphyAkwiwu/MultiStateMethods.All methods provide unbiased risk estimates for transition times when the true progression hazards are time independent. With more realistic models in which progression hazards are dependent on time since state entry, only BayesTSM and smms yield unbiased risk estimates for transition times.In situations with weakly identifiable likelihoods, the smms package may suffer from numerical and optimization problems. The BayesTSM package overcomes these problems by applying regularized parameter estimation using weakly informative priors.Methods for multistate cancer models, more specifically with unobservable precursor-to-cancer transition, are strongly affected by the time dependency of the hazard. An inappropriate choice can lead to biased parameter estimates.

Indexed as

Disease ProgressionEarly Detection of CancerNeoplasmsColorectal NeoplasmsComputer SimulationHumansModels, StatisticalProportional Hazards ModelsRisk Assessmentcancer screening and surveillanceinterval-censored datamultistate modelsnatural historysimulation studysurvival analysis

Identifiers

PMID41821401
PMCPMC13242538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.